home / stock / apyx / apyx news

APYX News and Press, Apyx Medical Corporation From 04/28/23

Stock Information
Company Name: Apyx Medical Corporation
Stock Symbol: APYX
Market: NASDAQ
Website: apyxmedical.com
Menu
APYX APYX Quote APYX Short APYX News APYX Articles APYX Message Board
Get APYX Alerts

News, Short Squeeze, Breakout and More Instantly...
APYX - Tempest, CVRx top healthcare gainers; Hillstream, Addus among losers

2023-04-28 10:03:38 ET Gainers: Tempest Therapeutics ( TPST ) +72% . CVRx ( CVRX ) +25% . ImmunoGen ( IMGN ) +22% . Apyx Medical ( APYX ) +17% . bluebird bio ( BLUE ) +17% . Losers: Hillstream BioPharma ( HILS ) -56%...
APYX - Apyx stock rises on FDA clearance of Renuvion APR Handpiece

2023-04-28 08:15:57 ET The U.S. Food and Drug Administration (FDA) granted 510(k) clearance to Apyx Medical's ( NASDAQ: APYX ) Renuvion APR Handpiece for coagulation of subcutaneous soft tissues after liposuction for aesthetic body contouring. "The Renuvion APR handpiece ...

APYX - Apyx Medical Corporation Receives FDA 510(k) Clearance for the Use of Renuvion® for Coagulation of Subcutaneous Soft Tissues Following Liposuction for Aesthetic Body Contouring

Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion ® , today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (“FDA...

APYX - Apyx Medical Corporation to Release First Quarter of Fiscal Year 2023 Financial Results on May 11, 2023

Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion ® , today announced that financial results for the first quarter of fiscal year 2023 will be released before...
APYX - Renuvion Wins ADDY® Award for #ThisIsMe Campaign

Renuvion Wins ADDY® Award for #ThisIsMe Campaign PR Newswire Advertising Industry's Largest Competition Recognizes Apyx Medical Device Campaign for Excellence in the Art of Advertising CLEARWATER, Fla. , March 27, 2023 /PRNewswire/ -- Apyx Medical Corp...

APYX - Apyx Medical Corporation (APYX) Q4 2022 Earnings Call Transcript

2023-03-16 11:30:05 ET Apyx Medical Corporation (APYX) Q4 2022 Earnings Conference Call March 16, 2023 8:00 AM ET Company Participants Charles Goodwin - President and Chief Executive Officer Tara Semb - Chief Financial Officer Conference Call Participants ...

APYX - Apyx Medical GAAP EPS of -$0.17 misses by $0.03, revenue of $12.61M misses by $0.43M

2023-03-16 07:03:55 ET Apyx Medical press release ( NASDAQ: APYX ): Q4 GAAP EPS of -$0.17 misses by $0.03 . Revenue of $12.61M (-25.0% Y/Y) misses by $0.43M . Advanced Energy revenue of $10.5 million, down 30% year-over-year. OEM revenue of $2.1 million, up...
APYX - Apyx Medical Corporation Reports Fourth Quarter and Full Year 2022 Financial Results; Introduces Full Year 2023 Financial Outlook

Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion®, today reported financial results for its fourth quarter and full year ended December 31, 2022, and introduced ...

APYX - Apyx Medical wins FDA nod for Renuvion APR Handpiece in new indication

Medical tech company Apyx Medical Corporation ( NASDAQ: APYX ) announced Monday that the FDA issued 510(k) clearance to use its Renuvion APR Handpiece in certain soft tissue-related medical procedures. Specifically, the new indication for the device covers the delivery of radiofrequen...

APYX - Apyx Medical Corporation Receives FDA 510(k) Clearance for the Use of Renuvion® to Coagulate and Contract Soft Tissues, Including Subcutaneous Tissue, Where Needed

Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion ® , today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (“FDA...
Previous 10 Next 10